Bone health specialist IBEX innovations has closed a £2m funding round to fund the next phase in its journey to turn every X-ray into an opportunity to diagnose osteoporosis.
The Durham-based firm has seen recent success, signing deals with X-ray and mammography imaging original equipment manufacturers in 2024.
The MedTech has also demonstrated that improving case finding can save the NHS money and is now looking to deploy its product, IBEX BH, in real-world clinical settings this year.
IBEX is looking to diagnose osteoporosis as it is a silent disease that often only comes to light following one or more fractures.
Chief clinical advisor, Dr Sarah Jarvis MBE believes that we are in a position of ‘waiting for failure’ before treating the disease.
“It has been such a privilege to work with the innovative team at IBEX Innovations for the last year,” she said.
“Their passion to improve outcomes for the millions of women at risk of osteoporosis-related fracture, and reduce the health inequalities that exist in this underserved area is so inspiring.
“I couldn’t be happier to see their efforts getting ever closer to fruition.”
Paul Scott, CEO at IBEX Innovations, added: “On a personal note, I would like to say a huge thank you to all of our investors for believing in and backing our vision, the healthcare professionals who want to see a better future for their patients and of course, to our world-class team – without whom none of this would be possible.”
Burberry and Virgin partner Vizzy gets busy with £3.7m raise